These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 30497814

  • 1. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP, Pereira MA, Dias AR, Yagi OK, Zaidan EP, Ribeiro-Júnior U, Zilberstein B, Cecconello I.
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, Puolakkainen P.
    Scand J Surg; 2007 Mar; 96(1):35-40. PubMed ID: 17461310
    [Abstract] [Full Text] [Related]

  • 3. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Rausei S, Ruspi L, Rosa F, Morgagni P, Marrelli D, Cossu A, Cananzi FC, Lomonaco R, Coniglio A, Biondi A, Cipollari C, Graziosi L, Fumagalli U, Casella F, Bertoli P, di Leo A, Alfieri S, Vittimberga G, Roviello F, Orsenigo E, Quagliuolo V, Montemurro S, Baiocchi G, Persiani R, Bencivenga M, Donini A, Rosati R, Sansonetti A, Ansaloni L, Zanoni A, Galli F, Dionigi G, Italian Research Group for Gastric Cancer (IRGGC).
    Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
    [Abstract] [Full Text] [Related]

  • 4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G, Aurello P, D'Angelo F, Cicchini C, Sternberg CN.
    Hepatogastroenterology; 2000 Dec; 47(35):1470-4. PubMed ID: 11100379
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B.
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [Abstract] [Full Text] [Related]

  • 6. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO.
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [Abstract] [Full Text] [Related]

  • 7. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A, Brillantino A, Marra A.
    Suppl Tumori; 2005 Jul; 4(3):S84-5. PubMed ID: 16437920
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J, Cao B, Wang Y, Xiao A, Qin J, Wu J, Yan Q, Hu Y, Yang C, Cao Z, Hu J, Yin P, Xie D, Gong J.
    Trials; 2018 Aug 09; 19(1):432. PubMed ID: 30092843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival benefit of extended D2 resection for proximal gastric cancer.
    Volpe CM, Driscoll DL, Miloro SM, Douglass HO.
    J Surg Oncol; 1997 Mar 09; 64(3):231-6. PubMed ID: 9121155
    [Abstract] [Full Text] [Related]

  • 13. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
    Galizia G, Lieto E, De Vita F, Castellano P, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, De Sena G, De Stefano L, Cardella F, Barbarisi A, Orditura M.
    Surgery; 2015 Feb 09; 157(2):285-96. PubMed ID: 25532433
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
    Yildirim E, Celen O, Berberoglu U.
    J Am Coll Surg; 2001 Jan 09; 192(1):25-37. PubMed ID: 11192920
    [Abstract] [Full Text] [Related]

  • 18. Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer.
    Kota I, Makoto H, Satoshi K, Yutaka T, Etsuro B, Masanori T.
    Eur J Surg Oncol; 2021 Feb 09; 47(2):456-462. PubMed ID: 32919813
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ.
    Lancet Oncol; 2010 May 09; 11(5):439-49. PubMed ID: 20409751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.